Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13 | 13 | 13 | 12 | 12 |
| Income taxes - deferred | N/A | 2 | 8 | 21 | 39 |
| Accounts receivable | -82 | 2 | 9 | 33 | -27 |
| Other Working Capital | 92 | 10 | 208 | -70 | -188 |
| Other Operating Activity | -2,108 | -1,313 | -1,323 | -1,094 | -1,101 |
| Operating Cash Flow | $-2,085 | $-1,286 | $-1,085 | $-1,098 | $-1,265 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -515 | 0 | N/A | N/A |
| Sale Of Investment | 0 | -10 | 113 | 0 | 83 |
| Other Investing Activity | 0 | 0 | 0 | -200 | -13 |
| Investing Cash Flow | $0 | $-524 | $113 | $-200 | $69 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -12 | -11 | -11 | -10 | -10 |
| Common Stock Issued | 7,246 | 0 | 0 | 0 | 0 |
| Other Financing Activity | 183 | 2,250 | 0 | 0 | 415 |
| Financing Cash Flow | $7,417 | $2,239 | $-11 | $-10 | $405 |
| Exchange Rate Effect | 2 | -1 | 6 | 0 | -1 |
| Beginning Cash Position | 3,923 | 3,495 | 4,473 | 5,781 | 6,574 |
| End Cash Position | 9,258 | 3,923 | 3,495 | 4,473 | 5,781 |
| Net Cash Flow | $5,332 | $429 | $-983 | $-1,309 | $-791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,085 | -1,286 | -1,085 | -1,098 | -1,265 |
| Free Cash Flow | -2,085 | -1,286 | -1,085 | -1,098 | -1,265 |